|
1
|
Ni MM, Wang YR, Wu WW, Xia CC, Zhang YH,
Xu J, Xu T and Li J: Novel Insights on Notch signaling pathways in
liver fibrosis. Eur J Pharmacol. 826:66–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li H, Lan J, Han C, Guo K, Wang G, Hu J,
Gong J, Luo X and Cao Z: Brg1 promotes liver fibrosis via
activation of hepatic stellate cells. Exp Cell Res. 364:191–197.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zhang Z, Yao Z, Wang L, Zhang F,
Shao J, Chen A and Zheng S: Activation of autophagy is required for
Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis
and hepatic stellate cell activation. Int Immunopharmacol.
56:148–155. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Panebianco C, Oben JA, Vinciguerra M and
Pazienza V: Senescence in hepatic stellate cells as a mechanism of
liver fibrosis reversal: A putative synergy between retinoic acid
and PPAR-gamma signalings. Clin Exp Med. 17:269–280. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tomita K, Teratani T, Suzuki T, Shimizu M,
Sato H, Narimatsu K, Okada Y, Kurihara C, Irie R, Yokoyama H, et
al: Free cholesterol accumulation in hepatic stellate cells:
Mechanism of liver fibrosis aggravation in nonalcoholic
steatohepatitis in mice. Hepatology. 59:154–169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He Y, Jin L, Wang J, Yan Z, Chen T and
Zhao Y: Mechanisms of fibrosis in acute liver failure. Liver Int.
35:1877–1885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang H, Ma R, Zou S, Wang Y, Li Z and Li
W: Reconstruction and analysis of the lncRNA-miRNA-mRNA network
based on competitive endogenous RNA reveal functional lncRNAs in
rheumatoid arthritis. Mol Biosyst. 13:1182–1192. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qu Z and Adelson DL: Evolutionary
conservation and functional roles of ncRNA. Front Genet. 3:2052012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng B, Jeong S, Zhu Y, Chen L and Xia Q:
miRNA and lncRNA as biomarkers in cholangiocarcinoma (CCA).
Oncotarget. 8:100819–100830. 2017.PubMed/NCBI
|
|
10
|
Huang GW, Xue YJ, Wu ZY, Xu XE, Wu JY, Cao
HH, Zhu Y, He JZ, Li CQ, Li EM and Xu LY: A three-lncRNA signature
predicts overall survival and disease-free survival in patients
with esophageal squamous cell carcinoma. BMC Cancer. 18:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding L, Wang M, Sun D and Li A: TPGLDA:
Novel prediction of associations between lncRNAs and diseases via
lncRNA-disease-gene tripartite graph. Sci Rep. 8:10652018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ye Y, Gao X and Yang N: LncRNA ZFAS1
promotes cell migration and invasion of fibroblast-like
synoviocytes by suppression of miR-27a in rheumatoid arthritis. Hum
Cell. 31:14–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grelet S, Link LA, Howley B, Obellianne C,
Palanisamy V, Gangaraju VK, Diehl JA and Howe PH: A regulated PNUTS
mRNA to lncRNA splice switch mediates EMT and tumour progression.
Nat Cell Biol. 19:1105–1115. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Szafranski P, Dharmadhikari AV, Brosens E,
Gurha P, Kolodziejska KE, Zhishuo O, Dittwald P, Majewski T, Mohan
KN, Chen B, et al: Small noncoding differentially methylated
copy-number variants, including lncRNA genes, cause a lethal lung
developmental disorder. Genome Res. 23:23–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li F, Huang C, Li Q and Wu X: Construction
and comprehensive analysis for dysregulated long non-coding RNA
(lncRNA)-associated competing endogenous RNA (ceRNA) network in
gastric cancer. Med Sci Monit. 24:37–49. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang X, Wu X, Chen F, He W, Chen X, Liu L
and Tang H: The profiles and networks of miRNA, lncRNA, mRNA, and
circRNA in benzo(a)pyrene-transformed bronchial epithelial cells. J
Toxicol Sci. 43:281–289. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xue WH, Fan ZR, Li LF, Lu JL, Ma BJ, Kan
QC and Zhao J: Construction of an oesophageal cancer-specific ceRNA
network based on miRNA, lncRNA, and mRNA expression data. World J
Gastroenterol. 24:23–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mao Y, Liu R, Zhou H, Yin S, Zhao Q, Ding
X and Wang H: Transcriptome analysis of miRNA-lncRNA-mRNA
interactions in the malignant transformation process of gastric
cancer initiation. Cancer Gene Ther. 24:267–275. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hyun J, Park J, Wang S, Kim J, Lee HH, Seo
YS and Jung Y: MicroRNA expression profiling in
CCl4-induced liver fibrosis of Mus musculus. Int J Mol
Sci. 17:9612016. View Article : Google Scholar :
|
|
21
|
Zhang K, Han X, Zhang Z, Zheng L, Hu Z,
Yao Q, Cui H, Shu G, Si M, Li C, et al: The liver-enriched
lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch
pathways. Nat Commun. 8:1442017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao JR, Qin XJ, Jiang H, Gao YC, Guo MF
and Jiang NN: Potential role of lncRNAs in contributing to
pathogenesis of chronic glomerulonephritis based on microarray
data. Gene. 643:46–54. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Betel D, Koppal A, Agius P, Sander C and
Leslie C: Comprehensive modeling of microRNA targets predicts
functional non-conserved and non-canonical sites. Genome Biol.
11:R902010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
25
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
The Gene Ontology Consortium, . The Gene
Ontology Resource: 20 years and still GOing strong. Nucleic Acids
Res. 47:D330–D338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kanehisa M, Sato Y, Furumichi M, Morishima
K and Tanabe M: New approach for understanding genome variations in
KEGG. Nucleic Acids Res. 47:D590–D595. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han JD, Bertin N, Hao T, Goldberg DS,
Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP and
Vidal M: Evidence for dynamically organized modularity in the yeast
protein-protein interaction network. Nature. 430:88–93. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cao H, Li S, Xie R, Xu N, Qian Y, Chen H,
Hu Q, Quan Y, Yu Z, Liu J and Xiang M: Exploring the mechanism of
dangguiliuhuang decoction against hepatic fibrosis by network
pharmacology and experimental validation. Front Pharmacol.
9:1872018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li P, Li Y, Zhu L, Yang Z, He J, Wang L,
Shang Q, Pan H, Wang H, Ma X, et al: Targeting secreted cytokine
BMP9 gates the attenuation of hepatic fibrosis. Biochim Biophys
Acta Mol Basis Dis. 1864:709–720. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matsuda M, Tsurusaki S, Miyata N, Saijou
E, Okochi H, Miyajima A and Tanaka M: Oncostatin M causes liver
fibrosis by regulating cooperation between hepatic stellate cells
and macrophages in mice. Hepatology. 67:296–312. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chi C, Liu XY, Hou F, Yu XZ, Li CY, Cui
LJ, Liu RX and Yin CH: Herbal compound 861 prevents hepatic
fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile
duct-ligated rats. BMC Complement Altern Med. 18:522018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Omar R, Yang J, Liu H, Davies NM and Gong
Y: Hepatic stellate cells in liver fibrosis and siRNA-based
therapy. Rev Physiol Biochem Pharmacol. 172:1–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pascher A, Nebrig M and Neuhaus P:
Irreversible liver failure: Treatment by transplantation: Part 3 of
a series on liver cirrhosis. Dtsch Arztebl Int. 110:167–173.
2013.PubMed/NCBI
|
|
37
|
Cheng L, Shi H, Wang Z, Hu Y, Yang H, Zhou
C, Sun J and Zhou M: IntNetLncSim: An integrative network analysis
method to infer human lncRNA functional similarity. Oncotarget.
7:47864–47874. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao Y, Wang H, Wu C, Yan M, Wu H, Wang J,
Yang X and Shao Q: Construction and investigation of
lncRNA-associated ceRNA regulatory network in papillary thyroid
cancer. Oncol Rep. 39:1197–1206. 2018.PubMed/NCBI
|
|
39
|
Zhou M, Wang X, Shi H, Cheng L, Wang Z,
Zhao H, Yang L and Sun J: Characterization of long non-coding
RNA-associated ceRNA network to reveal potential prognostic lncRNA
biomarkers in human ovarian cancer. Oncotarget. 7:12598–12611.
2016.PubMed/NCBI
|
|
40
|
Xu JH, Chang WH, Fu HW, Yuan T and Chen P:
The mRNA, miRNA and lncRNA networks in hepatocellular carcinoma: An
integrative transcriptomic analysis from Gene Expression Omnibus.
Mol Med Rep. 17:6472–6482. 2018.PubMed/NCBI
|
|
41
|
Wei S, Wang Q, Zhou H, Qiu J, Li C, Shi C,
Zhou S, Liu R and Lu L: miR-455-3p alleviates hepatic stellate cell
activation and liver fibrosis by suppressing HSF1 expression. Mol
Ther Nucleic Acids. 16:758–769. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen N, Geng Q, Zheng J, He S, Huo X and
Sun X: Suppression of the TGF-β/Smad signaling pathway and
inhibition of hepatic stellate cell proliferation play a role in
the hepatoprotective effects of curcumin against alcohol-induced
hepatic fibrosis. Int J Mol Med. 34:1110–1116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang K, Tang Y, Yan F, Zhu J and Li J:
Potent inhibition of TGF-β signaling pathway regulator Abl:
Potential therapeutics for hepatic fibrosis. J Recept Signal
Transduct Res. 35:410–419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xu A, Li Y, Zhao W, Hou F, Li X, Sun L,
Chen W, Yang A, Wu S, Zhang B, et al: PHP14 regulates hepatic
stellate cells migration in liver fibrosis via mediating TGF-β1
signaling to PI3Kγ/AKT/Rac1 pathway. J Mol Med (Berl). 96:119–133.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou L, Dong X, Wang L, Shan L, Li T, Xu
W, Ding Y, Lai M, Lin X, Dai M, et al: Casticin attenuates liver
fibrosis and hepatic stellate cell activation by blocking
TGF-β/Smad signaling pathway. Oncotarget. 8:56267–56280.
2017.PubMed/NCBI
|
|
46
|
Zhang Y, Xu Y, Feng L, Li F, Sun Z, Wu T,
Shi X, Li J and Li X: Comprehensive characterization of lncRNA-mRNA
related ceRNA network across 12 major cancers. Oncotarget.
7:64148–64167. 2016.PubMed/NCBI
|
|
47
|
Zhou M, Diao Z, Yue X, Chen Y, Zhao H,
Cheng L and Sun J: Construction and analysis of dysregulated
lncRNA-associated ceRNA network identified novel lncRNA biomarkers
for early diagnosis of human pancreatic cancer. Oncotarget.
7:56383–56394. 2016.PubMed/NCBI
|
|
48
|
Leti F, Legendre C, Still CD, Chu X,
Petrick A, Gerhard GS and DiStefano JK: Altered expression of
MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates
CXCL5 in hepatic stellate cells. Transl Res. 190:25.e21–39.e21.
2017. View Article : Google Scholar
|
|
49
|
Yu F, Lu Z, Chen B, Dong P and Zheng J:
Identification of a novel lincRNA-p21-miR-181b-PTEN signaling
cascade in liver fibrosis. Mediators Inflamm. 2016:98565382016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen MJ, Wang XG, Sun ZX and Liu XC:
Diagnostic value of LncRNA-MEG3 as a serum biomarker in patients
with hepatitis B complicated with liver fibrosis. Eur Rev Med
Pharmacol Sci. 23:4360–4367. 2019.PubMed/NCBI
|
|
51
|
Cao Y, Wang P, Ning S, Xiao W, Xiao B and
Li X: Identification of prognostic biomarkers in glioblastoma using
a long non-coding RNA-mediated, competitive endogenous RNA network.
Oncotarget. 7:41737–41747. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Heinrichs D, Knauel M, Offermanns C,
Berres ML, Nellen A, Leng L, Schmitz P, Bucala R, Trautwein C,
Weber C, et al: Macrophage migration inhibitory factor (MIF) exerts
antifibrotic effects in experimental liver fibrosis via CD74. Proc
Natl Acad Sci USA. 108:17444–17449. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang XH, Yan M, Liu L, Wu TJ, Ma LL and
Wang LX: Expression of discoidin domain receptors (DDR2) in
alcoholic liver fibrosis in rats. Arch Med Res. 41:586–592. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yang J, Zheng J, Wu L, Shi M, Zhang H,
Wang X, Xia N, Wang D, Liu X, Yao L, et al: NDRG2 ameliorates
hepatic fibrosis by inhibiting the TGF-β1/Smad pathway and altering
the MMP2/TIMP2 ratio in rats. PLoS One. 6:e277102011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hyun J, Wang S, Kim J, Rao KM, Park SY,
Chung I, Ha CS, Kim SW, Yun YH and Jung Y: MicroRNA-378 limits
activation of hepatic stellate cells and liver fibrosis by
suppressing Gli3 expression. Nat Commun. 7:109932016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang F, Hao M, Jin H, Yao Z, Lian N, Wu
L, Shao J, Chen A and Zheng S: Canonical hedgehog signalling
regulates hepatic stellate cell-mediated angiogenesis in liver
fibrosis. Br J Pharmacol. 174:409–423. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chung SI, Moon H, Ju HL, Cho KJ, Kim DY,
Han KH, Eun JW, Nam SW, Ribback S, Dombrowski F, et al: Hepatic
expression of Sonic Hedgehog induces liver fibrosis and promotes
hepatocarcinogenesis in a transgenic mouse model. J Hepatol.
64:618–627. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhu J, Zhang Z, Zhang Y, Li W, Zheng W, Yu
J, Wang B, Chen L, Zhuo Q, Chen L, et al: MicroRNA-212 activates
hepatic stellate cells and promotes liver fibrosis via targeting
SMAD7. Biochem Biophys Res Commun. 496:176–183. 2018. View Article : Google Scholar : PubMed/NCBI
|
